B Cell News and Research

RSS

Antibody combination produces a synergistic response in difficult-to-treat pediatric cancers

A combination of anti-cancer antibodies produced a powerfully synergistic response in two hard-to-treat pediatric cancers, according to a new study, in mice, led by researchers at the Stanford University School of Medicine.

19 Jan 2022

New method reverses insecticide resistance using CRISPR/Cas9 technology

Insecticides play a central role in efforts to counter global impacts of mosquito-spread malaria and other diseases, which cause an estimated 750,000 deaths each year. These insect-specific chemicals, which cost more than $100 million to develop and bring to market, also are critical to controlling insect-driven damage on crops that poses a challenge to food security.

18 Jan 2022

Scientists assess ACE2 binding and antigenicity of Mu (B.1.621) and A.2.5 spikes

To gain a better understanding of the antigenic properties of Mu and A.2.5 Spikes, Canadian scientists evaluated their capacity to interact with ACE2 and performed binding and neutralization assays with plasma from vaccinated individuals.

18 Jan 2022

Contagious cancers can jump between marine clam species, study shows

A contagious blood cancer jumped from one species of clam to another and spread among clams living in the Atlantic Ocean and Mediterranean Sea, shows a study published today in eLife.

18 Jan 2022

MD Anderson and Eisbach Bio collaborate to develop precision oncology drugs

The University of Texas MD Anderson Cancer Center and Eisbach Bio GmbH today announced a strategic research collaboration to jointly discover and develop precision oncology drugs that target synthetic lethal engines key to tumor genome evolution.

18 Jan 2022

Hospital room surfaces unlikely to be a source of SARS-CoV-2 transmission

Hospital rooms where COVID patients were treated had little to no active virus contaminations on surfaces, according to a study at Duke University Hospital that adds to the body of research on how the pandemic respiratory virus is spread.

18 Jan 2022

New genomic signature can spot aggressive tumor cells from primary, untreated prostate cancers

Many cases of early prostate cancer are dominated by cells that are slow-growing, often leading to a clinical decision to monitor for progression before initiating treatments that can have adverse side effects.

18 Jan 2022

New pathways responsible for hepatocellular carcinoma identified

Hepatocellular carcinoma (HCC) is the most common type of primary liver cancer. It is one of leading causes of cancer-related deaths globally, with more than 700,000 new cases and 600,000 estimated HCC deaths each year.

18 Jan 2022

Subcutaneous nanotherapy can make immunomodulation more effective in people with type 1 diabetes

Individuals living with type 1 diabetes must carefully follow prescribed insulin regimens every day, receiving injections of the hormone via syringe, insulin pump or some other device. And without viable long-term treatments, this course of treatment is a lifelong sentence.

18 Jan 2022

COVID-19 during pregnancy may induce fetal immune response even in the absence of placental infection

SARS-CoV-2 infection during pregnancy may cause inflammatory immune responses in the fetus, even if the virus does not infect the placenta, according to a small National Institutes of Health study.

18 Jan 2022

Study finds COVID booster maintains strong T cell response against Omicron

New study results posted to the medRxiv* preprint server found that COVID vaccine boosters increase immunity by enhancing T cell immune memory. In the face of the severe acute respiratory syndrome coronavirus 2 (SARS‑CoV‑2) Omicron variant, vaccinated people who had received a third booster shot maintained high T cell responses than people with naturally acquired immunity or vaccine-induced immunity from two doses of the SARS‑CoV‑2 vaccine.

18 Jan 2022

New perspective on SARS-CoV-2 breakthrough infections and booster shot restoration of vaccine efficacy

A recent article published in the journal Science explains how SARS-CoV-2 variants can bypass vaccine-induced immune defenses. However, immunity is restorable with a booster shot. The paper's authors outlined the importance of a booster shot in maintaining immunity and preventing severe infection.

18 Jan 2022

B Cell News and Research

Antibody combination produces a synergistic response in difficult-to-treat pediatric cancers

New method reverses insecticide resistance using CRISPR/Cas9 technology

Scientists assess ACE2 binding and antigenicity of Mu (B.1.621) and A.2.5 spikes

Contagious cancers can jump between marine clam species, study shows

MD Anderson and Eisbach Bio collaborate to develop precision oncology drugs

Hospital room surfaces unlikely to be a source of SARS-CoV-2 transmission

New genomic signature can spot aggressive tumor cells from primary, untreated prostate cancers

New pathways responsible for hepatocellular carcinoma identified

Subcutaneous nanotherapy can make immunomodulation more effective in people with type 1 diabetes

COVID-19 during pregnancy may induce fetal immune response even in the absence of placental infection

Study finds COVID booster maintains strong T cell response against Omicron

New perspective on SARS-CoV-2 breakthrough infections and booster shot restoration of vaccine efficacy

Respiratory viruses lacking NS2 protein can be destroyed by the body's immune response

Chinese scientists reveal key role of lysosome cell death regulator in lung tumor survival

Direct effect of SARS-CoV-2 on the kidney

New blood test for glioblastoma diagnosis may soon be a reality

Study reveals a causal link between deficiency in Parkinson’s disease gene and reduced immunoaging

Study reveals a causal link between deficiency in Parkinson’s disease gene and reduced immunoaging

Exploring SARS-CoV-2 Omicron variant’s neutralizing capacity of booster vaccines

Comparison of antibody responses and vaccine effectiveness in healthcare workers post-primary COVID-19 vaccination

Industry focus eBook - Cell and gene therapy (2nd edition) eBook

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News